Immunic

IMUXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$194.788 M

$14.30 -1.65%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$97.2M

Loss-making

Shares outstanding

136,214,825

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#268Minerva NeurosciencesNERV$198.9M
#269PepGenPEPG$197.1M
#270ImmunicIMUX$194.8M
#271Tonix PharmaceuticalsTNXP$191.8M
#272Korro BioKRRO$191.1M

Where these numbers come from

Share counts and financials for Immunic are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.